Protagonist Therapeutics: Q1 Earnings Insights

Protagonist Therapeutics PTGX reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Protagonist Therapeutics beat estimated earnings by 8.22%, reporting an EPS of $-0.67 versus an estimate of $-0.73.

Revenue was down $25.72 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 3.74% drop in the share price the next day.

To track all earnings releases for Protagonist Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.